Year: 2022

ISLAND PARK, N.Y., Nov. 15, 2022 (GLOBE NEWSWIRE) — Global Diversified Marketing Group Inc., a Delaware corporation (OTC: GDMK) (the “Company”) is pleased to announce that its Nutraceutical Ezlyv gummy supplement line is now available for purchase on the Amazon global shopping platform (www.amazon.com). Global Diversified Marketing Group is confident that by selling Ezlyv Supplements on the Amazon Global Online Shopping Platform should generate increased revenues for the company. This Direct-To-Consumer (DTC) distribution channel will certainly complement its already marketed brand from its own website (www.ezlyv.com) “We believe selling our nutraceutical products on Amazon should also help build a strong brand recognition for Ezlyv and all of its products for many years to come,” stated Global Diversified Marketing Group President...

LONGITUDINAL COMPOSITE SECTION – CHIMO MINE GOLD SYSTEM – 221115 PRESS RELEASE LONGITUDINAL COMPOSITE SECTION – CHIMO MINE GOLD SYSTEM – 221115 PRESS RELEASEVAL-D’OR, Quebec, Nov. 15, 2022 (GLOBE NEWSWIRE) — Cartier Resources Inc. (TSX-V: ECR) (“Cartier”) announces work progress on the Chimo Mine Project through, among other things, drill results of its ongoing drilling program on the Chimo Mine property and contiguous West Nordeau deposit of the East Cadillac property. Both properties, 100% owned by Cartier, are located 45 km east of the Val-d’Or mining camp. The results available from the laboratory to date for the current drilling program are as follows:In the East Chimo Mine Sector, one of the holes intersected 9.1 g/t Au over 1.0 m included in 4.5 g/t Au over 2.5 m also included in 2.0 g/t Au over...

DEVON, Pa., Nov. 15, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders, today announced that the European Commission (EC) has granted orphan drug designation to cannabidiol, the active ingredient in its transdermal gel, Zygel™, for the treatment of 22q11.2 deletion syndrome (22q). “We are pleased to have been granted orphan drug designation in the U.S. and now the EU, which we believe reflects the unmet medical need for new therapies to treat 22q,” said Armando Anido, Chairman and Chief Executive Officer of Zynerba. “Orphan drug designation is another important step forward in advancing Zygel as a potential new treatment option for patients with 22q.” Orphan drug designation is granted...

NEW CANAAN, Conn., Nov. 15, 2022 (GLOBE NEWSWIRE) — NewLake Capital Partners, Inc. (OTCQX: NLCP) (“The Company” or “NewLake”), a leading provider of real estate capital to state-licensed cannabis operators, today announced that Anthony Coniglio, President and Chief Executive Officer, will participate in the following November 2022 investor conferences. MJ BizCon 2022 – CannaVestCannabis Real Estate Investment Opportunities PanelLas Vegas Convention Center at Las Vegas, NVWednesday, November 16th at 2:15 p.m. PTRegister here. Bisnow’s National Cannabis Commercial Real Estate SummitNational Cannabis Commercial Real Estate Panel Wednesday, November 30th at 12:00 p.m. ETRegister here. To schedule a one-on-one meeting with NewLake’s management team, please email KCSA Strategic Communications at NewLake@kcsa.com. About NewLake...

Figure 1 Midland-Rio Tinto Tete Nord LocationFigure 2 2022 VTEM Survey CoverageFigure 3 2022-2023 Drilling AreasFigure 4 Rochette Ni-Cu ShowingFigure 5 Bonhomme – New Ultramafic IntrusionsMONTREAL, Nov. 15, 2022 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the start of a maiden drilling program by Rio Tinto Exploration Canada Inc. (“RTEC”) on the Tête Nord nickel-copper (“Ni-Cu”) property. This property, located near the town of La Tuque, Quebec, is currently wholly owned by Midland but is under option by RTEC since December 2021. Highlights:Commencement of a drilling program totalling 3,750 metres on 10 new VTEM targets including extensions of several known showings. Five (5) areas of interest: Bonhomme, Savane, Rochette, Cabouron, and Tête Sud. Rochette...

TORONTO, Nov. 15, 2022 (GLOBE NEWSWIRE) —  Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and nine-month period ended September 30, 2022. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”). Recent HighlightsTotal Natesto® prescriptions in the US rose 69% year-over-year in the third quarter of 2022 and were up approximately 10% sequentially over the fiscal 2022 second quarter Natesto® returns to the Canadian market with shipments resuming late in the third quarter The Company continues its preparations for the re-launch of Noctiva™ in the US Additional non-dilutive financing of US$10.0 million from First Generation Capital during the third...

HEXO to provide bulk supply to Entourage over three-year period for multi-channel distribution This news release constitutes a “designated news release” for the purposes of HEXO’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. GATINEAU, Quebec, Nov. 15, 2022 (GLOBE NEWSWIRE) — HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO”), a leading producer of high-quality cannabis products, today announced the execution of a long-term supply agreement (the “Supply Agreement”) with Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (“Entourage”), a Canadian producer and distributor of award-winning cannabis products. Under the Supply Agreement, HEXO will provide Entourage with bulk dried cannabis and soft gel capsules, to be marketed...

Concept LVT Will Combine Desktop Vape Power and Flavor in Standard Vape Cartridge Format PHOENIX, Nov. 15, 2022 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that its subsidiary Jupiter Research, LLC (“Jupiter”), a leading inhalation technology company, will launch a proprietary initiative called Concept LVT, a first-of-its-kind, patent-pending rig-less dab solution that is an affordable, easy and clean way to experience cannabis concentrates. Concept LVT is an advanced vaporizer that looks and feels like a regular 510 vape cartridge, but operates like a more powerful desktop vaporizer. Consumers will...